Ameritas Investment Partners’s Intersect ENT, Inc XENT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-2,690
| Closed | -$75K | – | 3365 |
|
|
2022
Q1 | $75K | Hold |
2,690
| – | – | ﹤0.01% | 1822 |
|
|
2021
Q4 | $73K | Hold |
2,690
| – | – | ﹤0.01% | 1888 |
|
|
2021
Q3 | $73K | Hold |
2,690
| – | – | ﹤0.01% | 1899 |
|
|
2021
Q2 | $46K | Hold |
2,690
| – | – | ﹤0.01% | 2254 |
|
|
2021
Q1 | $56K | Hold |
2,690
| – | – | ﹤0.01% | 2024 |
|
|
2020
Q4 | $62K | Hold |
2,690
| – | – | ﹤0.01% | 1861 |
|
|
2020
Q3 | $44K | Hold |
2,690
| – | – | ﹤0.01% | 1921 |
|
|
2020
Q2 | $36K | Hold |
2,690
| – | – | ﹤0.01% | 2036 |
|
|
2020
Q1 | $32K | Hold |
2,690
| – | – | ﹤0.01% | 1918 |
|
|
2019
Q4 | $67K | Buy |
2,690
+410
| +18% | +$8.31K | ﹤0.01% | 1746 |
|
|
2019
Q3 | $39K | Hold |
2,280
| – | – | ﹤0.01% | 2029 |
|
|
2019
Q2 | $52K | Hold |
2,280
| – | – | ﹤0.01% | 1891 |
|
|
2019
Q1 | $73K | Hold |
2,280
| – | – | ﹤0.01% | 1677 |
|
|
2018
Q4 | $64K | Hold |
2,280
| – | – | ﹤0.01% | 1668 |
|
|
2018
Q3 | $66K | Hold |
2,280
| – | – | ﹤0.01% | 1830 |
|
|
2018
Q2 | $85K | Hold |
2,280
| – | – | ﹤0.01% | 1645 |
|
|
2018
Q1 | $90K | Hold |
2,280
| – | – | ﹤0.01% | 1557 |
|
|
2017
Q4 | $74K | Hold |
2,280
| – | – | ﹤0.01% | 1685 |
|
|
2017
Q3 | $70K | Hold |
2,280
| – | – | ﹤0.01% | 1675 |
|
|
2017
Q2 | $64K | Buy |
2,280
+292
| +15% | +$6.61K | ﹤0.01% | 1745 |
|
|
2017
Q1 | $34K | Buy |
+1,988
| New | +$27.8K | ﹤0.01% | 2098 |
|
Ameritas Investment Partners's XENT Position: Q2 2022 in Review
Ameritas Investment Partners sold out of Intersect ENT, Inc (XENT) in Q2 2022, closing a stake of 2,690 shares — an estimated $75K sold.
Ameritas Investment Partners first reported a position in XENT in Q1 2017 and held it in 21 quarters. The position peaked at $90K in Q1 2018. 0 funds tracked by Wall St. Rank hold XENT as of Q2 2022.
- Ameritas Investment Partners reported no remaining Intersect ENT, Inc position as of Q2 2022 after selling out during the quarter.
- Ameritas Investment Partners sold 2,690 Intersect ENT, Inc shares in Q2 2022, an estimated $75K.
- Ameritas Investment Partners first reported a position in Intersect ENT, Inc in Q1 2017 and held it in 21 quarters.
- Ameritas Investment Partners's Intersect ENT, Inc position peaked at $90K in Q1 2018.
- 0 funds tracked by Wall St. Rank held Intersect ENT, Inc as of Q2 2022.
Based on Ameritas Investment Partners's 13F filing for Q2 2022, filed 12 Aug 2022.